Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recurrence
×
Bendamustine Hydrochloride
×
90 days
×
Clear all
Filters
3
NCT06522737
2026-02-11
TERZO
SecuraBio
Phase 3
Recruiting
124 enrolled
NCT05300282
2026-01-28
FIL_A-BEGEV
Fondazione Italiana Linfomi - ETS
Phase 1/2
Recruiting
122 enrolled